Gedeon Richter Teases Denosumab Partnering Opportunity In Japan
Prolia/Xgeva Biosimilar US And EU Filings Are Expected Later In 2024
While investigating the potential of the Japanese market for its denosumab, Gedeon Richter is preparing for several regulatory filings, including its tocilizumab biosimilar.
